Related Experiment Videos

Contemporary diagnosis and management of hypercholesterolemia in elderly acute myocardial infarction patients: a

Alan K Berger1, Susan J Duval, Chris Armstrong

  • 1Section of Cardiovascular Medicine, Department of Medicine, and the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN 55454, USA. berger1217@aol.com

The American Journal of Geriatric Cardiology
|January 12, 2007
PubMed

Insights

Elderly patients with acute myocardial infarction (AMI) are less likely to receive crucial lipid-lowering therapy. This study highlights the underutilization of statins in older AMI populations, emphasizing the need for improved treatment strategies.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Pharmacology

Background:

  • Limited data exist on hypercholesterolemia management in elderly patients experiencing acute myocardial infarction (AMI).
  • Understanding prescription patterns of lipid-lowering agents in this demographic is crucial for improving cardiovascular care.
  • Identifying factors associated with underutilization of these therapies is essential for targeted interventions.

Purpose of the Study:

  • To describe in-hospital and discharge prescription patterns of lipid-lowering agents in elderly patients with AMI.
  • To identify factors associated with low utilization rates of lipid-lowering therapies in this patient group.
  • To assess the impact of age on statin prescription following AMI.

Main Methods:

  • Analysis of the Minnesota Heart Survey, a population-based surveillance project.
  • Retrospective abstraction of medical records from 2773 patients aged 30 years and older hospitalized with AMI between 2001-2002.
  • Statistical analysis to determine factors associated with lipid-lowering agent prescription.

Main Results:

  • Statin prescription at discharge decreased significantly with age: 74.6% ( <65 years), 63.2% (65-74 years), and 38.5% (≥75 years).
  • Statin utilization correlated positively with other standard AMI therapies (aspirin, beta-blockers, ACE inhibitors/ARBs, reperfusion therapy).
  • Statin use was more common in patients undergoing percutaneous coronary intervention compared to coronary artery bypass surgery.

Conclusions:

  • Elderly patients with AMI are significantly less likely to receive recommended lipid-lowering therapy.
  • There is a critical need to ensure appropriate treatment with lipid-lowering agents for elderly AMI patients without contraindications.
  • Further research and clinical practice adjustments are necessary to address age-related disparities in cardiovascular pharmacotherapy.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...